Both in Pharmaceuticals
Prestige Consumer Healthcare vs NewAmsterdam Pharma Company N.V
Over the past year PBH returned −19.0% and NAMS returned −47.1%; their daily moves had a correlation of 0.04.
PBH −19.0% NAMS −47.1%Growth of $1, one year, split-adjusted
| Metric | PBH | NAMS |
|---|---|---|
| Price | $49.06 | $20.06 |
| Market cap | $2.32B | $2.40B |
| Today | +0.64% | −3.37% |
| 1 month | +9.6% | −17.0% |
| 6 months | −10.9% | −29.4% |
| Year to date | −20.5% | −42.8% |
| 1 year | −19.2% | −44.0% |
| Revenue growth (YoY) | +6.5% | −80.7% |
| Gross margin | 51.3% | 100.0% |
| Net margin | 11.0% | −1732.9% |
| P/E (TTM) | 13.5× | — |
| Price / sales | 2.1× | 336.7× |
| Net cash | -$1.95B | $633.9M |
| Dividend yield | — | — |
| Volatility (60d) | 30.7% | 50.9% |
| Short % of float | 8.5% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).